Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-25

FDA Approved: ABACAVIR SULFATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Abacavir Sulfate submitted by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • abacavir sulfate (abacavir sulfate)

Snippet

SUPPL AP for ABACAVIR SULFATE (ABACAVIR SULFATE)